Tl-895, A First-In-Class, Covalent Bruton Tyrosine Kinase Inhibitor (Btki) For The Treatment Of Myelofibrosis (Mf) Patients (Pts) With Severe Thrombocytopenia (Platelets (Plts) <50 K/Ul)
TL-895
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Tl-895, A First-In-Class, Covalent Bruton Tyrosine Kinase Inhibitor (Btki) For The Treatment Of Myelofibrosis (Mf) Patients (Pts) With Severe Thrombocytopenia (Platelets (Plts) <50 K/Ul) ### Output: TL-895